News | ASTRO | December 06, 2019

ASTRO Congratulates Stephen Hahn, M.D., for Securing Senate Committee Approval to lead FDA

Hahn has served on the ASTRO Board of Directors and has broad knowledge as a clinician, researcher, educator and administrative leader

Stephen Hahn, M.D., FASTRO

Stephen Hahn, M.D., FASTRO

December 6, 2019 — The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, M,D,, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA). Next, Senate Majority Leader Mitch McConnell (R-Ky.) will need to schedule a full Senate vote to confirm Hahn.

"On behalf of our more than 10,000 members, ASTRO commends Dr. Hahn for his thoughtful answers outlining his commitment to consumer safety during the committee hearing. We are pleased that Dr. Hahn received the votes needed to secure committee approval and will move on to a final confirmation vote. We join the growing number of research, provider and patient groups who also support Dr. Hahn, and we urge the Senate to swiftly confirm his nomination as head of the FDA," said Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors.

Hahn, the chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, was nominated Nov. 1 by President Trump to be the nation’s 24th FDA Commissioner. On behalf of ASTRO, DeWeese and other radiation oncology leaders expressed their support of Dr. Hahn's nomination when it was announced by the White House. The Cancer Leadership Council, a coalition of approximately 30 professional societies, cancer patient organizations and research organizations including ASTRO, also voiced its support of Hahn earlier this week.

Related content:

ASTRO supports nomination of Stephen Hahn, M.D., FASTRO, to lead U.S. FDA

Related Content

ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio

Image by Adam Radosavljevic from Pixabay 

News | Radiology Business | January 27, 2020
January 27, 2020 —  Hg, a specialist private equity investor focused on software and service businesses, announced th
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Gadolinium based contrast dye in brain MRI

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | January 17, 2020
January 17, 2020 — Bracco Diagnostics Inc., the U.
Imaging Technology News (ITN) has been acquired by Wainscot Media
News | Imaging Technology News - ITN | January 14, 2020
January 14, 2020 — Park Ridge, N.J.-based publisher Wainscot Medi...
Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population

Trends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population. Chart courtesy of the American Cancer Society

News | Radiation Oncology | January 13, 2020
January 13, 2020 — The cancer death rate declined
Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital.

Professor Samer Ezziddin, M.D., from Saarland University/Saarland University Hospital. Image courtesy of Saarland University/Thorsten Mohr

 

News | Prostate Cancer | January 13, 2020
January 13, 2020 — When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewha
Partners of Collaborative Imaging experience billing collection improvements of over 25 percent while reducing operating costs by 30 percent

Image courtesy of Philips Healthcare

News | Radiology Business | January 08, 2020
January 8, 2020 — The $18 billion radiology industry continues to face a growing threat of consolidation, resulting i